Cencora Acquires Retina Consultants of America to Expand Specialty Medicine Presence

126

Cencora, a leading healthcare company, has announced the acquisition of Retina Consultants of America (RCA) from Webster Equity Partners for $4.6 billion. This strategic move aims to strengthen Cencora’s position in the specialty medicine market, particularly in the field of ophthalmology.

RCA, a prominent network of retina specialists, focuses on treating complex eye conditions such as macular degeneration and diabetic retinopathy. The acquisition will add nearly 300 highly skilled physicians to Cencora’s portfolio, further expanding its reach and capabilities.

This deal follows Cencora’s investment in OneOncology, a network of cancer specialists. These strategic acquisitions align with Cencora’s broader strategy of expanding its presence in high-growth specialty markets.

The acquisition of RCA is expected to drive long-term growth and profitability for Cencora. By leveraging its scale and expertise, Cencora aims to improve patient access to specialized care, enhance operational efficiency, and drive innovation in the field of ophthalmology.

In addition to the acquisition news, Cencora also provided an upbeat outlook for the upcoming year. The company raised its 2025 earnings forecast, surpassing analyst expectations. This positive outlook reflects the strength of Cencora’s core business and its ability to capitalize on growth opportunities in the healthcare market.

Cencora’s strong financial performance and strategic acquisitions position the company well for future growth. As the healthcare industry continues to evolve, Cencora is committed to delivering innovative solutions and improving patient outcomes.